|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] Business Development Associate ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
1³â¡è |
ä¿ë½Ã |
03.17 |
|
|
(ÁÖ)¿¡½º¾ØÁö¹ÙÀÌ¿ÀÅØ |
ÀüÇ¥ÀÔ·Â&±âÀ塤ÀåºÎÁ¤¸®&´õÁ¸ ¿Ü Á¤±ÔÁ÷ ¸ðÁý °ø°í - °æ·Â
°æ±â ¿ëÀνà | °íµîÇб³ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
2³â¡è |
ä¿ë½Ã |
02.26 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CRA I/II
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
03.19 |
|
|
À̴ϽºÆ®¿¡½ºÆ¼(ÁÖ) |
R&Dº»ºÎ RAÆÀ ÀÎÇã°¡ ´ã´ç °æ·Â ä¿ë
°æ±â ¿ëÀνà | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
1³â¡è |
ä¿ë½Ã |
11.03 |
|
|
(ÁÖ)»çÀ̳ؽº |
¹°·ùÆÀ(ICC Inventory) °æ·ÂÁ÷ ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý»êÁö¿ø/¹°·ù/±¸¸Å |
2³â¡è |
ä¿ë½Ã |
11.14 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CTA I/II, Sr.CTA
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CTA/CRC |
1³â¡è |
ä¿ë½Ã |
07.21 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] PV Associate ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
2³â¡è |
ä¿ë½Ã |
04.23 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] HR Associate ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Àλç/ÀÎÀç°³¹ß/ä¿ë/±³À° |
2³â¡è |
ä¿ë½Ã |
04.23 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Feasibility - Site ID Specialist
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
SSU |
2³â¡è |
ä¿ë½Ã |
07.21 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] BD Associateä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
1³â¡è |
ä¿ë½Ã |
04.02 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] Clinical Data Analyst II ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
STAT/DM |
1³â¡è |
ä¿ë½Ã |
04.02 |
|
|
(ÁÖ)¸ÞµðÇïÇÁ¶óÀÎ |
CRºÎ¼ SSU ¾÷¹« Á¤±ÔÁ÷¿ø ä¿ë°ø°í
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
SSU |
1³â¡è |
»ó½Ãä¿ë |
02.23 |
|
|
¾È±¹¾àÇ°(ÁÖ) |
¾È±¹¾àÇ°(ÁÖ) Á¾ÇÕº´¿ø»ç¾÷ºÎ MR ¸ðÁý(°æ·Â)
´ëÀü ÀüÁö¿ª, Ãæ³² ÀüÁö¿ª, ÃæºÏ ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
04.29 |
|
|
Novotech |
Associate Clinical Data Manager
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
STAT/DM |
1³â¡è |
ä¿ë½Ã |
04.22 |
|
|
(ÁÖ)¿Ã¸®ºêÇコÄɾî |
¿Ã¸®ºêÀӻ󿬱¸¼¾ÅÍ Á¤±ÔÁ÷ ä¿ë
°æ±â ¿ëÀνà | ´ëÇÐ(4³â) Á¹¾÷ |
¼ö½Ãä¿ë |
1³â¡è |
ä¿ë½Ã |
04.19 |
|